BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 15114022)

  • 1. Mouse models for studying orthopoxvirus respiratory infections.
    Schriewer J; Buller RM; Owens G
    Methods Mol Biol; 2004; 269():289-308. PubMed ID: 15114022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models of orthopoxvirus infection.
    Chapman JL; Nichols DK; Martinez MJ; Raymond JW
    Vet Pathol; 2010 Sep; 47(5):852-70. PubMed ID: 20682806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling orthopoxvirus infections--200 years after Jenner's revolutionary immunization.
    Niemiałtowski MG; Toka FN; Malicka E; Gieryńska ; Spohr de Faundez I; Schollenberger A
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):373-8. PubMed ID: 9017154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Taterapox Virus in Small Animals.
    Parker S; Crump R; Hartzler H; Buller RM
    Viruses; 2017 Aug; 9(8):. PubMed ID: 28763036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response.
    Lustig S; Maik-Rachline G; Paran N; Melamed S; Israely T; Erez N; Orr N; Reuveny S; Ordentlich A; Laub O; Shafferman A; Velan B
    Vaccine; 2009 Mar; 27(11):1691-9. PubMed ID: 19195492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of human orthopoxvirus infections and differentiation of smallpox virus with real-time PCR.
    Putkuri N; Piiparinen H; Vaheri A; Vapalahti O
    J Med Virol; 2009 Jan; 81(1):146-52. PubMed ID: 19031452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Danger to the human caused by animal poxvirus following discontinuation of mandatory vaccination against smallpox].
    Mayr A
    Hautarzt; 1985 Sep; 36(9):493-5. PubMed ID: 2999033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rabbitpox: a model of airborne transmission of smallpox.
    Nalca A; Nichols DK
    J Gen Virol; 2011 Jan; 92(Pt 1):31-5. PubMed ID: 20965981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge.
    Yang G; Pevear DC; Davies MH; Collett MS; Bailey T; Rippen S; Barone L; Burns C; Rhodes G; Tohan S; Huggins JW; Baker RO; Buller RL; Touchette E; Waller K; Schriewer J; Neyts J; DeClercq E; Jones K; Hruby D; Jordan R
    J Virol; 2005 Oct; 79(20):13139-49. PubMed ID: 16189015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection induced in mice against a lethal orthopox virus by the Lister strain of vaccinia virus and modified vaccinia virus Ankara (MVA).
    Abdalrhman I; Gurt I; Katz E
    Vaccine; 2006 May; 24(19):4152-60. PubMed ID: 16603280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunomodulatory proteins of orthopoxviruses].
    Shchelkunov SN
    Mol Biol (Mosk); 2003; 37(1):41-53. PubMed ID: 12624944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. II. Pathogenesis.
    Jacoby RO; Bhatt PN
    Lab Anim Sci; 1987 Feb; 37(1):16-22. PubMed ID: 3035274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host.
    Fang M; Cheng H; Dai Z; Bu Z; Sigal LJ
    Virology; 2006 Feb; 345(1):231-43. PubMed ID: 16256161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
    Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
    J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Virology of Orthopoxviruses with Special Reference to Monkeypox Virus.
    Rohaim MA; Naggar RFE; Atasoy MO; Munir M
    Adv Exp Med Biol; 2024; 1451():111-124. PubMed ID: 38801574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smallpox vaccines: targets of protective immunity.
    Moss B
    Immunol Rev; 2011 Jan; 239(1):8-26. PubMed ID: 21198662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectromelia virus infections of mice as a model to support the licensure of anti-orthopoxvirus therapeutics.
    Parker S; Siddiqui AM; Painter G; Schriewer J; Buller RM
    Viruses; 2010 Sep; 2(9):1918-1932. PubMed ID: 21994714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When good vaccines go wild: Feral Orthopoxvirus in developing countries and beyond.
    Moussatché N; Damaso CR; McFadden G
    J Infect Dev Ctries; 2008 Jun; 2(3):156-73. PubMed ID: 19738346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding orthopoxvirus interference with host immune responses to inform novel vaccine design.
    Pickup DJ
    Expert Rev Vaccines; 2007 Feb; 6(1):87-95. PubMed ID: 17280481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smallpox, Monkeypox and Other Human Orthopoxvirus Infections.
    Shchelkunova GA; Shchelkunov SN
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.